▶ 調査レポート

ドラベ症候群治療薬の世界市場（～2026年）
• 英文タイトル：Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ドラベ症候群治療薬の世界市場（～2026年） / Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026 / MRC2-11QY11710資料のイメージです。• レポートコード：MRC2-11QY11710
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はドラベ症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ドラベ症候群治療薬の競争状況、市場シェア
・世界のドラベ症候群治療薬市場：種類別市場規模 2015年-2020年（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）
・世界のドラベ症候群治療薬市場：種類別市場規模予測 2021年-2026年（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）
・世界のドラベ症候群治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他）
・世界のドラベ症候群治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他）
・北米のドラベ症候群治療薬市場分析：米国、カナダ
・ヨーロッパのドラベ症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのドラベ症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のドラベ症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのドラベ症候群治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Biscayne Pharmaceuticals, Inc.、GW Pharmaceuticals Plc、INSYS Therapeutics, Inc.、OPKO Health, Inc.、PTC Therapeutics, Inc.、Sage Therapeutics, Inc.、Xenon Pharmaceuticals Inc.、Zogenix, Inc.
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market
The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Dravet Syndrome Thereapeutics Scope and Market Size
Dravet Syndrome Thereapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dravet Syndrome Thereapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biscayne Pharmaceuticals, Inc.
GW Pharmaceuticals Plc
INSYS Therapeutics, Inc.
OPKO Health, Inc.
PTC Therapeutics, Inc.
Sage Therapeutics, Inc.
Xenon Pharmaceuticals Inc.
Zogenix, Inc.

Market segment by Type, the product can be split into
BIS-001
Cannabidiol
CUR-1916
SAGE-217
Others
Market segment by Application, split into
Clinic
Hospital
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dravet Syndrome Thereapeutics Revenue
1.4 Market by Type
1.4.1 Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 BIS-001
1.4.3 Cannabidiol
1.4.4 CUR-1916
1.4.5 SAGE-217
1.4.6 Others
1.5 Market by Application
1.5.1 Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Dravet Syndrome Thereapeutics Market Perspective (2015-2026)
2.2 Global Dravet Syndrome Thereapeutics Growth Trends by Regions
2.2.1 Dravet Syndrome Thereapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dravet Syndrome Thereapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dravet Syndrome Thereapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Dravet Syndrome Thereapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Thereapeutics Players by Market Size
3.1.1 Global Top Dravet Syndrome Thereapeutics Players by Revenue (2015-2020)
3.1.2 Global Dravet Syndrome Thereapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Dravet Syndrome Thereapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dravet Syndrome Thereapeutics Market Concentration Ratio
3.2.1 Global Dravet Syndrome Thereapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Thereapeutics Revenue in 2019
3.3 Dravet Syndrome Thereapeutics Key Players Head office and Area Served
3.4 Key Players Dravet Syndrome Thereapeutics Product Solution and Service
3.5 Date of Enter into Dravet Syndrome Thereapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Dravet Syndrome Thereapeutics Historic Market Size by Type (2015-2020)
4.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)
5.2 Global Dravet Syndrome Thereapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Dravet Syndrome Thereapeutics Market Size (2015-2020)
6.2 Dravet Syndrome Thereapeutics Key Players in North America (2019-2020)
6.3 North America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
6.4 North America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Dravet Syndrome Thereapeutics Market Size (2015-2020)
7.2 Dravet Syndrome Thereapeutics Key Players in Europe (2019-2020)
7.3 Europe Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
7.4 Europe Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

8 China
8.1 China Dravet Syndrome Thereapeutics Market Size (2015-2020)
8.2 Dravet Syndrome Thereapeutics Key Players in China (2019-2020)
8.3 China Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
8.4 China Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Dravet Syndrome Thereapeutics Market Size (2015-2020)
9.2 Dravet Syndrome Thereapeutics Key Players in Japan (2019-2020)
9.3 Japan Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
9.4 Japan Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Dravet Syndrome Thereapeutics Market Size (2015-2020)
10.2 Dravet Syndrome Thereapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

11 India
11.1 India Dravet Syndrome Thereapeutics Market Size (2015-2020)
11.2 Dravet Syndrome Thereapeutics Key Players in India (2019-2020)
11.3 India Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
11.4 India Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Dravet Syndrome Thereapeutics Market Size (2015-2020)
12.2 Dravet Syndrome Thereapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020)
12.4 Central & South America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Biscayne Pharmaceuticals, Inc.
13.1.1 Biscayne Pharmaceuticals, Inc. Company Details
13.1.2 Biscayne Pharmaceuticals, Inc. Business Overview
13.1.3 Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Introduction
13.1.4 Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020))
13.1.5 Biscayne Pharmaceuticals, Inc. Recent Development
13.2 GW Pharmaceuticals Plc
13.2.1 GW Pharmaceuticals Plc Company Details
13.2.2 GW Pharmaceuticals Plc Business Overview
13.2.3 GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Introduction
13.2.4 GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.2.5 GW Pharmaceuticals Plc Recent Development
13.3 INSYS Therapeutics, Inc.
13.3.1 INSYS Therapeutics, Inc. Company Details
13.3.2 INSYS Therapeutics, Inc. Business Overview
13.3.3 INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction
13.3.4 INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.3.5 INSYS Therapeutics, Inc. Recent Development
13.4 OPKO Health, Inc.
13.4.1 OPKO Health, Inc. Company Details
13.4.2 OPKO Health, Inc. Business Overview
13.4.3 OPKO Health, Inc. Dravet Syndrome Thereapeutics Introduction
13.4.4 OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.4.5 OPKO Health, Inc. Recent Development
13.5 PTC Therapeutics, Inc.
13.5.1 PTC Therapeutics, Inc. Company Details
13.5.2 PTC Therapeutics, Inc. Business Overview
13.5.3 PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction
13.5.4 PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.5.5 PTC Therapeutics, Inc. Recent Development
13.6 Sage Therapeutics, Inc.
13.6.1 Sage Therapeutics, Inc. Company Details
13.6.2 Sage Therapeutics, Inc. Business Overview
13.6.3 Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Introduction
13.6.4 Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.6.5 Sage Therapeutics, Inc. Recent Development
13.7 Xenon Pharmaceuticals Inc.
13.7.1 Xenon Pharmaceuticals Inc. Company Details
13.7.2 Xenon Pharmaceuticals Inc. Business Overview
13.7.3 Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Introduction
13.7.4 Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.7.5 Xenon Pharmaceuticals Inc. Recent Development
13.8 Zogenix, Inc.
13.8.1 Zogenix, Inc. Company Details
13.8.2 Zogenix, Inc. Business Overview
13.8.3 Zogenix, Inc. Dravet Syndrome Thereapeutics Introduction
13.8.4 Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020)
13.8.5 Zogenix, Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Dravet Syndrome Thereapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Dravet Syndrome Thereapeutics Revenue
Table 3. Ranking of Global Top Dravet Syndrome Thereapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dravet Syndrome Thereapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of BIS-001
Table 6. Key Players of Cannabidiol
Table 7. Key Players of CUR-1916
Table 8. Key Players of SAGE-217
Table 9. Key Players of Others
Table 10. Global Dravet Syndrome Thereapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Dravet Syndrome Thereapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Dravet Syndrome Thereapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Dravet Syndrome Thereapeutics Market Share by Regions (2015-2020)
Table 14. Global Dravet Syndrome Thereapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Dravet Syndrome Thereapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Dravet Syndrome Thereapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Dravet Syndrome Thereapeutics Players
Table 21. Global Dravet Syndrome Thereapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Dravet Syndrome Thereapeutics Market Share by Players (2015-2020)
Table 23. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2019)
Table 24. Global Dravet Syndrome Thereapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Dravet Syndrome Thereapeutics Product Solution and Service
Table 27. Date of Enter into Dravet Syndrome Thereapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Dravet Syndrome Thereapeutics Market Size Share by Type (2015-2020)
Table 31. Global Dravet Syndrome Thereapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2015-2020)
Table 33. Global Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Dravet Syndrome Thereapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 37. North America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 39. North America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 43. Europe Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 45. Europe Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 49. China Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 51. China Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 55. Japan Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 57. Japan Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 61. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 67. India Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 69. India Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Dravet Syndrome Thereapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Dravet Syndrome Thereapeutics Market Share (2019-2020)
Table 73. Central & South America Dravet Syndrome Thereapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Dravet Syndrome Thereapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Dravet Syndrome Thereapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Dravet Syndrome Thereapeutics Market Share by Application (2015-2020)
Table 77. Biscayne Pharmaceuticals, Inc. Company Details
Table 78. Biscayne Pharmaceuticals, Inc. Business Overview
Table 79. Biscayne Pharmaceuticals, Inc. Product
Table 80. Biscayne Pharmaceuticals, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 81. Biscayne Pharmaceuticals, Inc. Recent Development
Table 82. GW Pharmaceuticals Plc Company Details
Table 83. GW Pharmaceuticals Plc Business Overview
Table 84. GW Pharmaceuticals Plc Product
Table 85. GW Pharmaceuticals Plc Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 86. GW Pharmaceuticals Plc Recent Development
Table 87. INSYS Therapeutics, Inc. Company Details
Table 88. INSYS Therapeutics, Inc. Business Overview
Table 89. INSYS Therapeutics, Inc. Product
Table 90. INSYS Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 91. INSYS Therapeutics, Inc. Recent Development
Table 92. OPKO Health, Inc. Company Details
Table 93. OPKO Health, Inc. Business Overview
Table 94. OPKO Health, Inc. Product
Table 95. OPKO Health, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 96. OPKO Health, Inc. Recent Development
Table 97. PTC Therapeutics, Inc. Company Details
Table 98. PTC Therapeutics, Inc. Business Overview
Table 99. PTC Therapeutics, Inc. Product
Table 100. PTC Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 101. PTC Therapeutics, Inc. Recent Development
Table 102. Sage Therapeutics, Inc. Company Details
Table 103. Sage Therapeutics, Inc. Business Overview
Table 104. Sage Therapeutics, Inc. Product
Table 105. Sage Therapeutics, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 106. Sage Therapeutics, Inc. Recent Development
Table 107. Xenon Pharmaceuticals Inc. Company Details
Table 108. Xenon Pharmaceuticals Inc. Business Overview
Table 109. Xenon Pharmaceuticals Inc. Product
Table 110. Xenon Pharmaceuticals Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 111. Xenon Pharmaceuticals Inc. Recent Development
Table 112. Zogenix, Inc. Business Overview
Table 113. Zogenix, Inc. Product
Table 114. Zogenix, Inc. Company Details
Table 115. Zogenix, Inc. Revenue in Dravet Syndrome Thereapeutics Business (2015-2020) (Million US$)
Table 116. Zogenix, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dravet Syndrome Thereapeutics Market Share by Type: 2020 VS 2026
Figure 2. BIS-001 Features
Figure 3. Cannabidiol Features
Figure 4. CUR-1916 Features
Figure 5. SAGE-217 Features
Figure 6. Others Features
Figure 7. Global Dravet Syndrome Thereapeutics Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Dravet Syndrome Thereapeutics Report Years Considered
Figure 12. Global Dravet Syndrome Thereapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Dravet Syndrome Thereapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Dravet Syndrome Thereapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Dravet Syndrome Thereapeutics Market Share by Players in 2019
Figure 17. Global Top Dravet Syndrome Thereapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Thereapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Dravet Syndrome Thereapeutics Revenue in 2019
Figure 19. North America Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Dravet Syndrome Thereapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介
  • ドラベ症候群治療の世界市場（～2026年）
    Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11711 2020年11月25日 97Pages
    当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...
  • レット症候群治療薬の世界市場（～2026年）
    Global Rett Syndrome Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY04506 2020年11月20日 95Pages
    当調査資料はレット症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...
  • プラダーウィリー症候群治療薬の世界市場（～2026年）
    Global Prader-Willi Syndrome Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY04348 2020年11月20日 99Pages
    当調査資料はプラダーウィリー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...
  • 転移性ブドウ膜黒色腫治療薬の世界市場（～2026年）
    Global Metastatic Uveal Melanoma Thereapeutics Market Insights and Forecast to 2026
    MRC2-11QY07682 2020年11月20日 115Pages
    当調査資料は転移性ブドウ膜黒色腫治療薬のグローバル市場について調査・分析したレポートです。種類別（スニチニブリンゴ酸塩、ビンクリスチン硫酸塩リポソーム、LY-2801653、酢酸ソトラスタウリン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...
  • 脆弱X症候群の世界市場（～2026年）
    Global Fragile X Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY11990 2020年11月25日 95Pages
    当調査資料は脆弱X症候群のグローバル市場について調査・分析したレポートです。種類別（ACT-01、AMO-01、ANAVEX-273、AUT-00206、ブリオスタチン-1、カンナビジオール、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...
  • 骨髄異形成症候群の世界市場（～2026年）
    Global Myelodysplastic Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY03885 2020年11月20日 131Pages
    当調査資料は骨髄異形成症候群のグローバル市場について調査・分析したレポートです。種類別（アルキル化剤、細胞毒性抗生物質、トポイソメラーゼ阻害剤、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...
  • シェーグレン症候群治療薬の世界市場（～2026年）
    Global Sjogren's Syndrome Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY04626 2020年11月20日 99Pages
    当調査資料はシェーグレン症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（一次、二次）市場規模、用途別（臨床、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...
  • 骨髄異形成症候群（MDS）治療薬の世界市場（～2026年）
    Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY03884 2020年11月20日 95Pages
    当調査資料は骨髄異形成症候群（MDS）治療薬のグローバル市場について調査・分析したレポートです。種類別（アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）市場規模、用途別（入院患者、外来患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...
  • 急性冠症候群治療薬の世界市場（～2026年）
    Global Acute Coronary Syndrome Therapeutics Market Insights and Forecast to 2026
    MRC2-11QY02086 2020年11月20日 111Pages
    当調査資料は急性冠症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（急性冠症候群第I相薬、急性冠症候群第II相薬、急性冠症候群第III相薬）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...
  • 短腸症候群の世界市場（～2026年）
    Global Short Bowel Syndrome Market Size, Status and Forecast 2020-2026
    MRC2-11QY04601 2020年11月20日 93Pages
    当調査資料は短腸症候群のグローバル市場について調査・分析したレポートです。種類別（GLP-2、成長ホルモン、グルタミン、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...
  • ドラベ症候群治療の世界市場（～2026年）ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …
  • 転移性ブドウ膜黒色腫治療薬の世界市場（～2026年）転移性ブドウ膜黒色腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metastatic Uveal Melanoma Thereapeu…
  • 脆弱X症候群の世界市場（～2026年）脆弱X症候群の世界市場（～2026年） Market Analysis and Insights: Global Fragile X Syndrome Market The global Fragile X Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fragile X Syndrome Scope and Market Size Fragile X Syndrome market is segment…
  • セロトニン症候群の世界市場（～2026年）セロトニン症候群の世界市場（～2026年） Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death. US accou…
  • 間欠的発熱症候群の世界市場（～2026年）間欠的発熱症候群の世界市場（～2026年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …